ASP Isotopes (NASDAQ:ASPI) Shares Gap Up – Here’s Why

ASP Isotopes Inc. (NASDAQ:ASPI) shares gapped up prior to trading on Monday . The stock had previously closed at $5.63, but opened at $6.00. ASP Isotopes shares last traded at $6.3160, with a volume of 1,708,767 shares changing hands.

Analyst Ratings Changes

ASPI has been the subject of a number of research reports. Weiss Ratings reaffirmed a “sell (d-)” rating on shares of ASP Isotopes in a research note on Monday, December 29th. Cantor Fitzgerald initiated coverage on shares of ASP Isotopes in a research report on Thursday, December 4th. They issued an “overweight” rating and a $13.00 price target on the stock. Canaccord Genuity Group reissued a “buy” rating and set a $11.00 price objective on shares of ASP Isotopes in a research note on Monday, November 24th. Finally, Loop Capital set a $15.00 target price on ASP Isotopes in a report on Monday, October 27th. Two research analysts have rated the stock with a Buy rating and one has given a Sell rating to the stock. According to MarketBeat, the stock currently has a consensus rating of “Hold” and an average price target of $13.00.

ASP Isotopes Stock Up 16.4%

The company has a market cap of $726.56 million, a P/E ratio of -5.04 and a beta of 3.47. The firm’s 50 day moving average price is $6.99 and its 200-day moving average price is $8.44. The company has a current ratio of 6.14, a quick ratio of 6.10 and a debt-to-equity ratio of 1.04.

ASP Isotopes (NASDAQ:ASPI) last issued its quarterly earnings data on Wednesday, November 19th. The company reported ($0.15) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.10) by ($0.05). The business had revenue of $4.89 million during the quarter, compared to analyst estimates of $2.25 million. ASP Isotopes had a negative net margin of 1,259.12% and a negative return on equity of 190.44%. As a group, equities research analysts expect that ASP Isotopes Inc. will post -0.24 EPS for the current year.

Insider Activity at ASP Isotopes

In other news, CEO Robert Ainscow sold 67,500 shares of the business’s stock in a transaction on Monday, November 17th. The stock was sold at an average price of $7.51, for a total transaction of $506,925.00. Following the completion of the transaction, the chief executive officer owned 1,579,693 shares of the company’s stock, valued at approximately $11,863,494.43. The trade was a 4.10% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, CFO Heather Kiessling sold 80,000 shares of the firm’s stock in a transaction on Thursday, December 18th. The stock was sold at an average price of $5.80, for a total value of $464,000.00. Following the transaction, the chief financial officer directly owned 732,500 shares of the company’s stock, valued at approximately $4,248,500. This represents a 9.85% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Insiders have sold 528,091 shares of company stock valued at $3,539,245 over the last three months. 14.40% of the stock is owned by insiders.

Institutional Inflows and Outflows

A number of large investors have recently modified their holdings of ASPI. MetLife Investment Management LLC increased its position in shares of ASP Isotopes by 22.1% during the first quarter. MetLife Investment Management LLC now owns 31,732 shares of the company’s stock valued at $149,000 after acquiring an additional 5,744 shares during the last quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. increased its position in shares of ASP Isotopes by 9.4% during the 1st quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 31,613 shares of the company’s stock valued at $148,000 after purchasing an additional 2,709 shares during the last quarter. Rhumbline Advisers raised its stake in shares of ASP Isotopes by 8.2% during the 1st quarter. Rhumbline Advisers now owns 65,326 shares of the company’s stock worth $306,000 after purchasing an additional 4,963 shares during the period. Exchange Traded Concepts LLC bought a new stake in shares of ASP Isotopes during the 2nd quarter worth $9,593,000. Finally, Harbour Capital Advisors LLC bought a new stake in shares of ASP Isotopes during the 2nd quarter worth $232,000. Institutional investors own 16.80% of the company’s stock.

About ASP Isotopes

ASP Isotopes Inc, a development stage advanced materials company, focuses on the production, distribution, marketing, and sale of isotopes. It engages in the production and commercialization of Molybdenum-100, a non-radioactive isotope for the medical industry; Carbon-14; and Silicon-28. The company is also developing Quantum Enrichment technology to produce Ytterbium-176, Nickel-64, Lithium 6, Lithium7, and Uranium-235. ASP Isotopes Inc was incorporated in 2021 and is headquartered in Washington, District Of Columbia.